31 reports

  • Identifying factors impacting market growth

The overdose of pain-relief medicines can also lead to migraine.

  • Pain Relief
  • United States
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co Ltd
  • 8.5.1 UNMET NEED
  • 7.1.6 ONZETRA XSAIL (SUMATRIPTAN SUCCINATE)

SUBJECTS REPORTED PAIN RELIEF IN LESS THAN ## MINUTES, WITH ##% OF SUBJECTS REPORTING PAIN RELIEF WITHIN ONE HOUR OF ADMINISTRATION OF A SINGLE ##MG SUBCUTANEOUS DOSE OF IMITREX INJECTION.

  • Pain Relief
  • United States
  • Allergan plc
  • Amgen Inc.
  • Pfizer Inc.

(USA) ##.

  • Pain Relief
  • United States
  • Demand
  • Market Competition
  • Market Shares
  • Sales of Top Anti-Migraine Products in 2017
  • ANTI-MIGRAINE DRUGS

The company' s Respiratory and Personal Care include Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp and ChapStick.

  • Pain Relief
  • United States
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.

(USA) ##.

  • Analgesic
  • Opioid
  • Pain Relief
  • United States
  • Market Shares

IN JULY 2014, GSK RECALLED PANADOL ADVANCE ## CT PAIN RELIEF PRODUCTS FROM PUERTO RICO CONSUMERS, AS IT LACKED A CHILD RESISTANT FEATURE AND IS NOT LABELED AS A PRODUCT " FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN".

  • Pain Relief
  • United States
  • AstraZeneca PLC
  • Mylan Inc.
  • Pfizer Inc.
  • Neurophyxia B.V. is an innovative clinical stage drug development company, focusing on disorders affecting the newborn child announces the start of formal preclinical development of 2-IB (manufacturing and safety studies).
  • OCT 31, 2010: NEURAXON REPORTS NXN-188 PHASE II DATA DEMONSTRATES EFFICACY IN ACUTE MIGRAINE

Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl Cysteine S Nitrosylase NOS1 or NOS1 or EC 1.14.13.39) - Pipeline Review, H1 2018 Summary Nitric Oxide Synthase Brain (Constitutive NOS or NC NOS or Neuronal NOS or bNOS or NOS Type I or Peptidyl...

  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • NeurAxon, Inc.
  • PAIN RELIEF DEVICE - PRODUCT STATUS
  • PAIN RELIEF DEVICE - PRODUCT DESCRIPTION

Pain Management Devices - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Pain Management Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Pain Management Devices currently in pipeline stage. The report provides comprehensive...

  • Clinical Trial
  • Drug Discovery And Development
  • Pain Relief
  • United States
  • Sanofi S.A.
  • PAIN RELIEF DEVICE - PRODUCT DESCRIPTION
  • PAIN RELIEF DEVICE - PRODUCT STATUS

Pain Management - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Pain Management - Medical Devices Pipeline Assessment, 2017" provides an overview of Pain Management currently in pipeline stage. The report provides comprehensive information on the pipeline products...

  • Clinical Trial
  • Drug Discovery And Development
  • Pain Relief
  • United States
  • GlobalData's company
  • 9.3 GLAXOSMITHKLINE (GSK)
  • 3.4 MIGRAINE SPECIFIC DRUGS

However, rizatriptan may provide better pain relief than many of the other triptans.

  • Pain Relief
  • United States
  • Endo International plc
  • Impax Laboratories, Inc.
  • Pfizer Inc.
  • Analgesics and Other Pain Relievers

Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide...

  • Pain Relief
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SECTION 2 - COMPANY ANALYSIS COMPANY OVERVIEW
  • Company Overview

BioElectronics Corp (BIEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...

  • Pain Relief
  • United States
  • World
  • Company Financials
  • BioElectronics Corporation
  • CAPSAICIN - DRUG PROFILE

Worth to note is the rapidly installed and long lasting pain relief achieved by the MCS-Injection therapy.

  • Arthritis
  • Pain Relief
  • Therapy
  • United States
  • Flex Pharma, Inc.
  • Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Product Development Milestones
  • Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Companies Involved in Therapeutics Development

Pain relief was sustained throughout ## hours.

  • OTC
  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • 4.3 Challenges

Example, one may experience headache pain as a vise-like band circling the head, while others fell a throbbing pain on one side of head.

  • Pain Relief
  • North America
  • United States
  • Forecast
  • Amgen Inc.
  • Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Product Development Milestones
  • Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Companies Involved in Therapeutics Development

Excessive use of acute pain-relief medication is common among people who suffer from migraine.

  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • Amgen Inc.
  • May 15, 2018: Zosano Pharma Announces First Quarter 2018 Financial Results
  • Jan 05, 2017: Zosano Pharma Announces Last Subject Treated in its Migraine Pivotal Trial

These symptoms include photophobia, A key secondary endpoint of this trial is pain relief at ## min, aimed at demonstrating the rapid relief profile of M##.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Zosano Pharma Corporation
  • NOV 09, 2016: COLUCID PHARMACEUTICALS ANNOUNCES 2016 THIRD QUARTER RESULTS AND CORPORATE HIGHLIGHTS

Both the ## mg and ## mg doses of lasmiditan were also more efficacious than placebo on headache pain relief at the two-hour time point (p ##. ##), as a rescue medication on headache pain freedom at the two-hour time point (p ##. ## and p ##. ##), in reducing migraine relat

  • Pain Relief
  • Pharmaceutical
  • United States
  • Supply
  • CoLucid Pharmaceuticals, Inc.
  • Product Development Milestones

These symptoms A key secondary endpoint of this trial is pain relief at ## min, aimed at demonstrating the rapid relief profile of M##.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Cluster Headache Syndrome - Companies Involved in Therapeutics Development
  • CLUSTER HEADACHE SYNDROME - PIPELINE BY CROSSJECT SA, H1 2018

Cluster headache is pain that occurs along one side of the head.

  • OTC
  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative

Bactine is an over-the-counter healthcare product, bringing both pain relief for first aid injuries and an antiseptic that kill germs.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Bayer AG

It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics.

  • Healthcare
  • Pain Relief
  • United States
  • M&A
  • Fagron NV
  • MTR-106 - DRUG PROFILE
  • DRUG TO AGONIZE MOR1 FOR MIGRAINE - DRUG PROFILE

Migraine - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Migraine - Pipeline Review, H1 2018, provides an overview of the Migraine (Central Nervous System) pipeline landscape. Migraine is a disorder characterized by repeated...

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics.

  • Healthcare
  • Pain Relief
  • United States
  • M&A
  • Fagron NV
  • KETOPROFEN - DRUG PROFILE
  • UBROGEPANT - DRUG PROFILE

A key secondary endpoint of this trial is pain relief at ## min, aimed at demonstrating the rapid relief profile of M##.

  • Pain Relief
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Pyralvex is used for the symptomatic relief of pain associated with recurrent mouth ulcers and denture irritation.

  • Cardiology
  • Pain Relief
  • Pharmaceutical
  • United States
  • Valeant Pharmaceuticals International, Inc.

Pyralvex is used for the symptomatic relief of pain associated with recurrent mouth ulcers and denture irritation.

  • Cardiology
  • Pain Relief
  • Pharmaceutical
  • United States
  • Valeant Pharmaceuticals International, Inc.

It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics.

  • Immunology
  • Pain Relief
  • United States
  • M&A
  • Perrigo Company
  • Other Developmental Activities
  • dihydroergotamine mesylate

Additional endpoints showed that levadex provided rapid and sustained pain relief for up to ## hours after dosing.

  • Ophthalmology
  • Pain Relief
  • United States
  • M&A
  • Allergan plc
  • FEATURED NEWS & PRESS RELEASES

Better tissue penetration should reduce inflammatory symptoms, which are key to preventing post-surgical side effects, in addition to providing longer lasting pain relief to patients. "

  • Eye Disease
  • Pain Relief
  • United States
  • Product Initiative
  • InSite Vision Incorporated